Some visit links earn us a commission.
Quick verdict
Mochi Health is the better pick for most patients on overall scoring. Flat monthly pricing, transparent compounded sourcing and no lock-in. Best fit for cash-pay patients who want predictable monthly billing.
That said, Hims & Hers wins on specific dimensions. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. The cheapest branded path is an oral GLP-1 pill from $149/mo plus a $149/mo membership, about $298/mo all-in. Injectable Wegovy or Zepbound runs higher.
Side-by-side
| Mochi Health | Hims & Hers | |
|---|---|---|
| Starts from | $178/mo (incl. medication) | $298/mo (incl. medication) |
| Monthly cost gap | Mochi Health is $120/mo cheaper than Hims & Hers | |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 3 days | 1 day |
| Consultation type | Live | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Mochi Health | Hims & Hers | |
|---|---|---|
| Pricing transparency | 9/10 | 6/10 |
| Cancellation terms | 9/10 | 9/10 |
| Onboarding experience | 8/10 | 9/10 |
| Medication options | 6/10 | 5/10 |
| Member reviews | 9/10 | 6/10 |
When to choose Mochi Health
Best for flat predictable cash-pay
Cash-pay patients who want predictable monthly pricing and a compounded GLP-1 path.
Mochi Health wins on pricing transparency, medication options, member reviews and runs $120/mo cheaper than Hims & Hers at the entry tier ($178 vs $298). Over a year that's $1,440 you keep. The caveat: Patients who specifically want FDA-approved branded Wegovy or Zepbound through insurance. Note also: Active in Lilly's 2025-2026 lawsuit against compounded tirzepatide pharmacies
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on onboarding experience on the dimensional scoring. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
If cost is your main filter
Mochi Health is the cheaper monthly: $178 all-in vs $298 for Hims & Hers. That's $120 a month or $1,440a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $360 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Mochi Health (month-to-month) and Hims & Hers (month-to-month) sit at the same cancellation tier. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Mochi Health cheaper than Hims & Hers?
Can I switch from Mochi Health to Hims & Hers mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
